[{"uuid": "a0c67a56-e125-3fd4-a413-a1dd7e167ef5", "title": "Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/applied-dna-completes-buildout-gmp-140000244.html", "providerPublishTime": 1736517600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sH3P6RxOhW9D0J7ISyoaTg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/c9f537b349468c713364afadeb177a58", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/BLKkigvBjmGPJoMF6SYgvg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/c9f537b349468c713364afadeb177a58", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APDN"]}, {"uuid": "ec0bfdfb-a867-3870-80e7-3598d1be2dec", "title": "Applied DNA Reschedules Investor Update Call in Observance of the  National Day of Mourning in Recognition of the Passing of  Former President Jimmy Carter", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/applied-dna-reschedules-investor-call-213000414.html", "providerPublishTime": 1736371800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sH3P6RxOhW9D0J7ISyoaTg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/c9f537b349468c713364afadeb177a58", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/BLKkigvBjmGPJoMF6SYgvg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/c9f537b349468c713364afadeb177a58", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APDN"]}, {"uuid": "086ecb0a-2a00-313f-8ad5-324e96c3b41b", "title": "APDN Files for Resale of 41.6 Million Shares by Selling Stockholders", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/apdn-files-resale-41-6-155706438.html", "providerPublishTime": 1732031826, "type": "STORY", "relatedTickers": ["APPDW"]}, {"uuid": "3dae349a-5357-3547-82a7-627a3a95fc1e", "title": "Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/applied-dna-sciences-apdn-reports-221502266.html", "providerPublishTime": 1734473702, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UACuRym2G7Sc_7yqOtSLVQ--~B/aD0yMzUxO3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0", "width": 3000, "height": 2351, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/4xltbIIZEXRptTswpC4cYw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APDN"]}, {"uuid": "9ab3be8e-0139-3ef4-b1a9-a24a776df36a", "title": "Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/applied-dna-announces-fourth-quarter-210500718.html", "providerPublishTime": 1734469500, "type": "STORY", "relatedTickers": ["APDN"]}, {"uuid": "80535dbe-5519-3613-8878-ac6ad12b700a", "title": "Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/applied-dna-report-fourth-quarter-150000907.html", "providerPublishTime": 1734361200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sH3P6RxOhW9D0J7ISyoaTg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/c9f537b349468c713364afadeb177a58", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/BLKkigvBjmGPJoMF6SYgvg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/c9f537b349468c713364afadeb177a58", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APDN"]}, {"uuid": "aebd5c2b-e3d7-3fab-9642-c4ec00dc8bee", "title": "Applied DNA Customer \u00daHKT Initiates Phase I Clinical Trial  for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/applied-dna-customer-hkt-initiates-140000934.html", "providerPublishTime": 1734530400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sH3P6RxOhW9D0J7ISyoaTg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/c9f537b349468c713364afadeb177a58", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/BLKkigvBjmGPJoMF6SYgvg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/c9f537b349468c713364afadeb177a58", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APDN"]}, {"uuid": "24319485-9696-3399-bf3a-842ac33c0ebe", "title": "Applied DNA Sciences: Fiscal Q4 Earnings Snapshot", "publisher": "Associated Press Finance", "link": "https://finance.yahoo.com/news/applied-dna-sciences-fiscal-q4-211202897.html", "providerPublishTime": 1734469922, "type": "STORY", "relatedTickers": ["APDN"]}, {"uuid": "8d0d9877-a04e-3266-8ef8-7a40a380c74c", "title": "Intellicheck Mobilisa, Inc. (IDN) Reports Q3 Loss, Misses Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/intellicheck-mobilisa-inc-idn-reports-223009005.html", "providerPublishTime": 1731537009, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UACuRym2G7Sc_7yqOtSLVQ--~B/aD0yMzUxO3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0", "width": 3000, "height": 2351, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/4xltbIIZEXRptTswpC4cYw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "bbc93a4b-7bd4-3994-8b31-fb979eebd3ac", "title": "GrafTech International (EAF) Reports Q3 Loss, Tops Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/graftech-international-eaf-reports-q3-125002129.html", "providerPublishTime": 1731415802, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/nxwFIPS2ImeTQYZMYlnAgg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209", "width": 900, "height": 600, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/b7m1GSxHeAeYrh4cHL3hRA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EAF"]}, {"uuid": "bbc828ac-4ce3-3473-a409-4a4fc6cf489a", "title": "Resideo Technologies (REZI) Q3 Earnings and Revenues Top Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/resideo-technologies-rezi-q3-earnings-225008743.html", "providerPublishTime": 1731019808, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83", "width": 900, "height": 633, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1wWgvR9AXA1o_EfTypadHw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["REZI"]}]